Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of CTMX will decline by -8.24% over the next 2 Weeks and hit $3.89 by Tuesday, April 7, 2026. In that time frame, CTMX's share price is expected to range between $3.46 and $4.32.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| Apr 8, 2026 | 3.41 | 3.90 | 4.36 |
| Apr 7, 2026 | 3.53 | 3.98 | 4.44 |
| Apr 6, 2026 | 3.88 | 4.30 | 4.76 |
| Apr 3, 2026 | 3.40 | 3.87 | 4.35 |
| Apr 2, 2026 | 3.48 | 3.97 | 4.41 |
| Apr 1, 2026 | 3.62 | 4.04 | 4.49 |
| Mar 31, 2026 | 3.68 | 4.13 | 4.56 |
| Mar 30, 2026 | 3.96 | 4.45 | 4.89 |
| Mar 27, 2026 | 3.57 | 4.01 | 4.48 |
| Mar 26, 2026 | 3.63 | 4.11 | 4.58 |
CTMX shares fell -0.47% in Wednesday, March 25, 2026's trading session, dropping from a previous close of $4.24 to move at $4.22. The stock demonstrated notable intraday movement (see CTMX's key stats for a full breakdown), fluctuating between $4.08 and $4.47, a +9.56% trading range. While recent weeks have seen some volatility, CTMX has managed to secure a -13.35% drop over the past 2 weeks. The downward price movement was accompanied by increased trading volume, with approximately 6.07M shares changing hands, 662.27K more than the previous session. This amounted to $25.62M in total market activity.
Will CTMX Continue Its Upward Trend?
According to analyst ratings and projections for CTMX, CytomX Therapeutics, Inc. shares are anticipated to increase by +3.14%, potentially reaching $4.36 per share by April 8, 2026. Short-term technical indicators currently suggest a neutral sentiment for CTMX. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 10 positive trading days within the past 30 sessions. Based on the CTMX stock forecast, now is a good time to buy CTMX stock because its current trading price is +8.17% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on CTMX covering social and institutional perspectives.
CTMX Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into CTMX's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 40.02% to 43.78%) suggest the stock is in a neutral to slightly bearish momentum phase. The 50-day RSI, at 48.49%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 51.20%, maintains a neutral outlook for the long term. Insights into CTMX's shareholder base show how institutional investors are positioning themselves during these momentum shifts
CytomX Therapeutics Short-Term Forecasts
CTMX Forecast For Next 5 Days
Our algorithm anticipates CytomX Therapeutics (CTMX) stock could hit $3.76 by Apr 01, 2026. This represents a -11.02% rise from today's price, following a +23.73% change over the past five days.
CTMX Forecast For Next 30 Days
Based on analysis of market trends, the outlook for CytomX Therapeutics, Inc. (CTMX) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $4.21, which would mean a -0.24% decrease from the current price of $4.22. Projections for this period range from a high of $5.92 to a low of $2.93.
CTMX Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for CytomX Therapeutics's price over the next three months point to a rise. CTMX stock is expected to peak at $22.67 on May 25, 2026 after potentially dipping to $14.88 on Apr 16, 2026. On average, CTMX is likely to trade around $18.18 in the coming 90 days.
CytomX Therapeutics Stock Forecast 2025
Based on our predictive models, CytomX Therapeutics (CTMX) is expected to trade between $14.88 and $24.59 throughout 2026. This would result in an average price of $18.73, potentially offering investors a +343.84% return from current levels.
CytomX Therapeutics, Inc. Monthly Forecast 2026–2027
March 2026
According to our latest forecast models, CytomX Therapeutics, Inc. (CTMX) is positioned to show a strong performance in March 2026. The price is predicted to move between $16.21 and $16.94, settling at an average of $16.56. This could translate to a +292.42% gain.
April 2026
Based on current market signals, CytomX Therapeutics, Inc. is projected to trend april 2026. We forecast a trading range from $14.88 to $20.46, with a likely average price of $17.37. Investors could expect a potential return of +311.61%.
May 2026
Our predictive algorithms indicate CytomX Therapeutics, Inc. stock may see a shift in May 2026. The expected range spans $19.66–$22.67, with an average target of $21.00. This represents a positive outlook and a possible gain of +397.63%.
June 2026
Analyzing established trends, CytomX Therapeutics, Inc. looks set to move in June 2026. Projections place the stock between $15.51 and $18.42, averaging around $16.34. This suggests a +287.20% gain from current levels.
July 2026
Market indicators suggest CytomX Therapeutics, Inc. could experience notable changes during July 2026. Prices could fluctuate within $15.91 to $18.91, with a midpoint forecast of $17.07. The stock might deliver a +304.50% gain.
August 2026
Forecasting for August 2026, models estimate that CytomX Therapeutics, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $15.22 and $20.46, averaging $17.01. This signals a positive trajectory with potential returns around +303.08%.
September 2026
According to our latest forecast models, CytomX Therapeutics, Inc. (CTMX) is positioned to show a strong performance in September 2026. The price is predicted to move between $15.81 and $22.96, settling at an average of $18.74. This could translate to a +344.08% gain.
October 2026
Based on current market signals, CytomX Therapeutics, Inc. is projected to trend october 2026. We forecast a trading range from $17.93 to $24.59, with a likely average price of $20.92. Investors could expect a potential return of +395.73%.
November 2026
Our predictive algorithms indicate CytomX Therapeutics, Inc. stock may see a shift in November 2026. The expected range spans $17.46–$23.46, with an average target of $19.40. This represents a positive outlook and a possible gain of +359.72%.
December 2026
Analyzing established trends, CytomX Therapeutics, Inc. looks set to move in December 2026. Projections place the stock between $20.45 and $24.40, averaging around $21.10. This suggests a +400.00% gain from current levels.
January 2027
Market indicators suggest CytomX Therapeutics, Inc. could experience notable changes during January 2027. Prices could fluctuate within $21.33 to $38.12, with a midpoint forecast of $28.76. The stock might deliver a +581.52% gain.
February 2027
Forecasting for February 2027, models estimate that CytomX Therapeutics, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $30.27 and $38.87, averaging $31.16. This signals a positive trajectory with potential returns around +638.39%.
March 2027
According to our latest forecast models, CytomX Therapeutics, Inc. (CTMX) is positioned to show a strong performance in March 2027. The price is predicted to move between $23.51 and $32.19, settling at an average of $25.21. This could translate to a +497.39% gain.
CTMX's history of dividends and stock splits also plays a role in long-term investor confidence.